Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Iglobe Capital Vcc A/C Igpf Iv (T21vc02073c-Sf001) investment portfolio
Iglobe Capital Vcc A/C Igpf Iv (T21vc02073c-Sf001) has made numerous investments in companies such as Accession Therapeutics within the Biotech sector.
vc
Portfolio
1
Team
0
Shareholding changes (3)
Iglobe Capital Vcc A/C Igpf Iv (T21vc02073c-Sf001)'s positions across portfolio companies2025
- A SHARES 0 → 5,000
2023
- ORDINARY 34,884 → 69,768
Articles (1)
- Accession Therapeutics secures £5.7m to advance targeted cancer immunotherapies26 Mar 2026Accession Therapeutics